Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking (NCT07459621)
Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking: A Randomized Controlled Trial
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to compare the effectiveness of two smoking cessation programs to determine which better helps people change their smoking behavior, the control or the experimental intervention? Both interventions include access to a mHealth app and other publicly available stop-smoking resources. The two app versions each include best practice advice and guidance for quitting smoking, but one includes additional content designed for people who aren't ready to quit smoking. The investigators hypothesize that people who receive the experimental intervention will be more likely to request additional stop-smoking resources offered through the intervention and report smoking abstinence after 6 months. The investigators also hypothesize people assigned to the experimental app will have better app engagement and be more likely to report positive changes in their smoking behavior and use of other evidence-based stop smoking treatments that are publicly available.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (8 items) and avoid the listed exclusions (5 items).
Location: Kaiser Permanente Center for Health Research — Portland, Oregon
Age range: 18 Years
🧪 Interventions in This Study
- Control Intervention (BEHAVIORAL)
- Experimental Intervention (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- A lifetime history of dementia or psychosis
- Visual impairments that prevent viewing phone content and they lack adaptive devices
- Report medical contra-indications for over-the-counter NRT use
- Due to the potential for bias introduced by fraudulent participants, other exclusions will be applied to deter fraudulent enrollment.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Kaiser Permanente Center for Health Research — Portland, Oregon
📞 Contact the Study Coordinator
Phone: (503) 335-2400
Email: jennifer.b.mcclure@kp.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Smoking Behaviors
- Nicotine Pouch Pharmacokinetics Abuse Liability — Knoxville, Tennessee
- Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand — Buffalo, New York
Explore by condition: All Smoking Behaviors clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.